Prolium's $50M Series A raise; COUR Pharma touts liver drug follow-up
Prolium's $50M Series A raise; COUR Pharma touts liver drug follow-up
Body unavailable. Use the original source.
Prolium's $50M Series A raise; COUR Pharma touts liver drug follow-up
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.